Recruiting PHASE2 INTERVENTIONAL 1-arm NCT07193654

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

Stupp Regimen Combined With Intrathecal Injection of Thiotepa for the Treatment of Glioblastoma With Ventricular Invasion or Meningeal Metastasis：a Prospective, Single-Arm, Exploratory Study

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions Glioblastoma (GBM)

Interventions Intrathecal injection of thiotepa Maximal surgical resection Radical radiotherapy Stupp regimen (oral temozolomide)

Updated 1 time since 2025 Last updated: Sep 24, 2025 Started: Apr 1, 2025 Primary completion: Apr 1, 2027 Completion: Apr 1, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07193654, this PHASE2 trial focuses on Glioblastoma (GBM) and remains actively recruiting participants. Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Recruiting — PHASE2 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China